Document is current
Any future updates will be listed below
-
Authors
Seppälä, Toni T. http://orcid.org/0000-0002-4940-3498
Ahadova, Aysel
Dominguez-Valentin, Mev
Macrae, Finlay
Evans, D. Gareth
Therkildsen, Christina
Sampson, Julian
Scott, Rodney
Burn, John
Möslein, Gabriela
Bernstein, Inge
Holinski-Feder, Elke
Pylvänäinen, Kirsi
Renkonen-Sinisalo, Laura
Lepistö, Anna
Lautrup, Charlotte Kvist
Lindblom, Annika
Plazzer, John-Paul
Winship, Ingrid
Tjandra, Douglas
Katz, Lior H.
Aretz, Stefan
Hüneburg, Robert
Holzapfel, Stefanie
Heinimann, Karl
Valle, Adriana Della
Neffa, Florencia
Gluck, Nathan
de Vos tot Nederveen Cappel, Wouter H.
Vasen, Hans
Morak, Monika
Steinke-Lange, Verena
Engel, Christoph
Rahner, Nils
Schmiegel, Wolff
Vangala, Deepak
Thomas, Huw
Green, Kate
Lalloo, Fiona
Crosbie, Emma J.
Hill, James
Capella, Gabriel
Pineda, Marta
Navarro, Matilde
Blanco, Ignacio
ten Broeke, Sanne
Nielsen, Maartje
Ljungmann, Ken
Nakken, Sigve
Lindor, Noralane
Frayling, Ian
Hovig, Eivind
Sunde, Lone
Kloor, Matthias
Mecklin, Jukka-Pekka
Kalager, Mette
Møller, Pål
-
Funding
Funding for this research was provided by:
Emil Aaltosen Säätiö (-)
Suomen Lääketieteen Säätiö (-)
Instrumentariumin Tiedesäätiö (-)
Sigrid Juséliuksen Säätiö (-)
Syöpäsäätiö (-)
Jane ja Aatos Erkon Säätiö (-)
- License Information
-
More Information
Article History
Received: 30 January 2019
Accepted: 20 February 2019
First Online: 28 February 2019
Ethics approval and consent to participate
: All reporting centers obtained informed consent for genetic testing and surveillance procedures. De-identified data was exported for the current study. No named registry needing approval was established for the current study.
: Not applicable.
: Toni Seppälä: a co-owner (20%) of Healthfund Finland Oy (educational and health care services in Finland, not related to patients or scope of this manuscript). Travel costs to a scientific meeting by Medtronic Finland.John Burn: a patent for high speed low cost tumor profiling pending to John Burn and QuantuMDx.All others: None declared.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
